DK1404304T3 - Tablet omfattende cetirizin og pseudoephedrin - Google Patents

Tablet omfattende cetirizin og pseudoephedrin

Info

Publication number
DK1404304T3
DK1404304T3 DK02743173T DK02743173T DK1404304T3 DK 1404304 T3 DK1404304 T3 DK 1404304T3 DK 02743173 T DK02743173 T DK 02743173T DK 02743173 T DK02743173 T DK 02743173T DK 1404304 T3 DK1404304 T3 DK 1404304T3
Authority
DK
Denmark
Prior art keywords
tablet
cetirizine
pseudoephedrine
combinations
treatment
Prior art date
Application number
DK02743173T
Other languages
Danish (da)
English (en)
Inventor
Domenico Fanara
Anthony Guichaux
Monique Berwaer
Michel Deleers
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Application granted granted Critical
Publication of DK1404304T3 publication Critical patent/DK1404304T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK02743173T 2001-06-28 2002-06-10 Tablet omfattende cetirizin og pseudoephedrin DK1404304T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30125001P 2001-06-28 2001-06-28
EP01115807 2001-06-28
PCT/EP2002/006342 WO2003002098A1 (fr) 2001-06-28 2002-06-10 Comprime contenant de la cetirizine et de la pseudoephedrine

Publications (1)

Publication Number Publication Date
DK1404304T3 true DK1404304T3 (da) 2009-07-13

Family

ID=56290291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02743173T DK1404304T3 (da) 2001-06-28 2002-06-10 Tablet omfattende cetirizin og pseudoephedrin

Country Status (22)

Country Link
EP (1) EP1404304B1 (fr)
JP (1) JP4041460B2 (fr)
KR (1) KR100926410B1 (fr)
CN (1) CN100490809C (fr)
AT (1) ATE432068T1 (fr)
AU (1) AU2002345024B2 (fr)
BR (1) BR0210650A (fr)
CA (1) CA2451519C (fr)
CZ (1) CZ20033454A3 (fr)
DK (1) DK1404304T3 (fr)
EE (1) EE05357B1 (fr)
ES (1) ES2324769T3 (fr)
HU (1) HU229803B1 (fr)
MX (1) MXPA03010430A (fr)
NZ (1) NZ530289A (fr)
PL (1) PL206069B1 (fr)
PT (1) PT1404304E (fr)
RO (1) RO122476B1 (fr)
RU (1) RU2286784C2 (fr)
SI (1) SI1404304T1 (fr)
SK (1) SK287645B6 (fr)
WO (1) WO2003002098A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090029314A (ko) * 2001-06-28 2009-03-20 유씨비 파쉼 소시에떼아노님 세티리진 및 슈도에페드린을 포함하는 정제
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
US20100172984A1 (en) * 2006-06-06 2010-07-08 Bijay Kumar Padhi tablet dosage form comprising cetirizine and pseudoephedrine
RU2446796C2 (ru) 2006-12-26 2012-04-10 Фармасайкликс, Инк. Способ использования ингибиторов гистондеацетилазы и мониторинга биомаркеров в комбинированной терапии
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
EP3431128A1 (fr) 2010-01-05 2019-01-23 MicroDose Therapeutx, Inc. Dispositif d'inhalation
KR101193495B1 (ko) * 2010-02-01 2012-10-23 한미사이언스 주식회사 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물
CN103002896A (zh) * 2010-06-16 2013-03-27 布鲁斯·钱德勒·梅 左西替利嗪和孟鲁司特在治疗流感、普通感冒和炎症中的用途
CN102302497A (zh) * 2011-05-18 2012-01-04 天圣制药集团股份有限公司 一种治疗过敏性鼻炎的制剂及其制备方法
KR20130009553A (ko) 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
MX365393B (es) 2011-09-13 2019-05-31 Pharmacyclics Llc Formulaciones de inhibidor de histona deacetilasa en combinación con bendamustina y usos de las mismas.
KR101372324B1 (ko) * 2012-02-09 2014-03-13 동국대학교 경주캠퍼스 산학협력단 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물
CA2901421A1 (fr) 2013-03-13 2014-10-09 Bruce Chandler May Utilisation de levocetirizine et de montelukast dans le traitement des maladies auto-immunes
RU2015134422A (ru) 2013-03-13 2017-04-18 Инфламматори Респонс Ресёрч, Инк. Применение левоцитиризина и монтелукаста при лечении васкулита
CN105517631A (zh) 2013-03-13 2016-04-20 炎症反应研究公司 左西替利嗪和孟鲁司特在治疗创伤性损伤中的用途
JP2017526728A (ja) 2014-09-15 2017-09-14 インフラマトリー・レスポンス・リサーチ・インコーポレイテッド 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト
WO2016140630A1 (fr) 2015-03-05 2016-09-09 PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. Composition effervescente comprenant de la lévocétirizine et de la pseudoéphédrine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0811374A1 (fr) * 1996-05-29 1997-12-10 Pfizer Inc. Formulation d'une combinaison de cetirizine et pseudoephedrine
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine

Also Published As

Publication number Publication date
RU2286784C2 (ru) 2006-11-10
SK15502003A3 (sk) 2004-05-04
PT1404304E (pt) 2009-06-26
EP1404304B1 (fr) 2009-05-27
SK287645B6 (sk) 2011-05-06
CA2451519A1 (fr) 2003-01-09
CA2451519C (fr) 2007-11-06
MXPA03010430A (es) 2004-12-06
SI1404304T1 (sl) 2009-10-31
ES2324769T3 (es) 2009-08-14
JP2004536829A (ja) 2004-12-09
EE05357B1 (et) 2010-12-15
AU2002345024B2 (en) 2006-09-07
BR0210650A (pt) 2004-10-05
PL206069B1 (pl) 2010-06-30
KR20040007756A (ko) 2004-01-24
EP1404304A1 (fr) 2004-04-07
HU229803B1 (en) 2014-07-28
CZ20033454A3 (cs) 2004-08-18
NZ530289A (en) 2004-11-26
JP4041460B2 (ja) 2008-01-30
HUP0400386A2 (hu) 2004-08-30
CN1520285A (zh) 2004-08-11
RO122476B1 (ro) 2009-07-30
KR100926410B1 (ko) 2009-11-12
CN100490809C (zh) 2009-05-27
HUP0400386A3 (en) 2006-02-28
WO2003002098A1 (fr) 2003-01-09
RU2004101231A (ru) 2005-04-20
PL366800A1 (en) 2005-02-07
EE200400005A (et) 2004-02-16
ATE432068T1 (de) 2009-06-15

Similar Documents

Publication Publication Date Title
DK1404304T3 (da) Tablet omfattende cetirizin og pseudoephedrin
DE60226702D1 (de) Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
DE60217363D1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen-abhängigen erkrankungen
DE60225385D1 (de) Autentisches Document und dessen Herstellungsverfahren
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
DE60216122D1 (de) Cysteinprotease-hemmer mit 2-cyano-4-amino-pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen
NO20034056D0 (no) Proliferative sykdommer
DK1513873T3 (da) Terapeutiske epitoper og anvendelser deraf
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
NO20055173D0 (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
NO20052278L (no) Piperazinyl- og diazapanyl-benzamider og -benztioamider
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
NO20051983D0 (no) 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav.
DK1546127T3 (da) Nye pyrimidinamidderivater og anvendelse deraf
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
ATE282607T1 (de) Tryptase-inhibitoren
ATE389392T1 (de) Paracetamol enthaltende tablette
DK1849468T3 (da) Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens